Penile cancer is a rare genitourinary malignancy that is associated with poor outcomes and
severely limited therapeutic options that are generally non-curative when used to treat …

Human papillomavirus (HPV) infection drives tumorigenesis in almost all cervical cancers
and a fraction of vulvar and penile cancers. Due to increasing incidence and low vaccination …

PURPOSE Patients with advanced penile squamous cell carcinoma have a poor prognosis
(21% 2-year overall survival [OS] from diagnosis). We assessed the activity of atezolizumab …

Background Treatment options for penile squamous cell carcinoma are limited. We sought to
investigate clinical outcomes and safety profiles of patients with penile squamous cell …

Objectives There is an unmet need for therapeutically relevant biomarkers for advanced
penile squamous cell carcinoma (pSCC). Proposed immunohistochemistry (IHC)-based …

Background: Treatment options for unresectable, locally advanced or metastatic penile
squamous cell carcinoma (SCC) are limited. Previous studies have shown that 40–62% of …

Penile squamous cell carcinoma (PSCC) accounts for over 95% of penile malignancies and
causes significant mortality and morbidity in develo** countries. Molecular mechanisms …

Penile cancer is an extremely rare malignancy that accounts for approximately 1% of cancer
deaths in the United States every year. While primary penile cancer can be managed …

Penile cancer (PeCa) is a rare disease worldwide, accounting for less than one percent of
all malignancies in men. It usually presents as a painless ulcer or lump on the head of the …

Background Penile squamous cell carcinoma (PSCC) is a rare malignancy with higher
incidence in develo** countries. Treatment options include surgery, radiation therapy, and …